Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07462377 |
| Title | A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | EpiBiologics |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| START Los Angeles | NOT_YET_RECRUITING | Los Angeles | California | 90025 | United States | Details |
| Astera Cancer Care | NOT_YET_RECRUITING | East Brunswick | New Jersey | 08816 | United States | Details |
| Sarah Cannon and HCA Research Institute | NOT_YET_RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| MD Anderson Cancer Center | NOT_YET_RECRUITING | Houston | Texas | 77030 | United States | Details |
| South Texas Accelerated Research Therapeutics (START) | RECRUITING | San Antonio | Texas | 78229 | United States | Details |